Evidence map›Paper›PMID 36002234›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2022

A Rapid Translational Immune Response Program in CD8 Memory T Lymphocytes.

Darin Salloum, Kamini Singh, Natalie R Davidson, Linlin Cao, David Kuo, Viraj R Sanghvi, Man Jiang, Maria Tello Lafoz, Agnes Viale, Gunnar Ratsch and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Darin SalloumCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY.
Kamini SinghCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY.
Natalie R DavidsonDepartment of Computer Science, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-1745-8072
Linlin CaoSwiss Institute for Experimental Cancer Research, EPFL, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-8667-1571
David KuoDepartment of Physiology, Biophysics, and Systems Biology, Weill Cornell Graduate School of Medical Sciences, New York, NY.
Viraj R SanghviCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY.
Man JiangCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID http://orcid.org/0000-0003-1818-7427
Maria Tello LafozImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY; and.
Agnes VialeIntegrated Genomics Operation, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID http://orcid.org/0000-0001-8644-9017
Gunnar RatschDepartment of Computer Science, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-5486-8532
Hans-Guido WendelCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY; wendelh@mskcc.org.ORCID http://orcid.org/0000-0001-7166-4670
Memorial Sloan Kettering Cancer Center · USSIB Swiss Institute of Bioinformatics · CHAlbert Einstein College of Medicine · USCornell University · USSwiss Cancer Center Léman · CH

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Translating Stress Response Targeted Therapy for B-Cell LymphomasP50CA192937 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ZELENETZ, ANDREW D. · 2016 to 2020
$10.9M
Towards targeting the lymphoma microenvironmentR35CA252982 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Hans-Guido Wendel · 2020 to 2026
$6.2M
Exploring oncogenic translation programs in cancerR01CA207217 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WENDEL, HANS-GUIDO · 2016 to 2020
$2.1M
Exploring the link between serine metabolism and epigenetic in lymphomaR01CA248168 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WENDEL, HANS-GUIDO · 2020 to 2020
$569k
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA192937NCI NIH HHS R01 CA207217NCI NIH HHS R01 CA248168NCI NIH HHS R35 CA252982
6 · The paper itself

Abstract

The activation of memory T cells is a very rapid and concerted cellular response that requires coordination between cellular processes in different compartments and on different time scales. In this study, we use ribosome profiling and deep RNA sequencing to define the acute mRNA translation changes in CD8 memory T cells following initial activation events. We find that initial translation enables subsequent events of human and mouse T cell activation and expansion. Briefly, early events in the activation of Ag-experienced CD8 T cells are insensitive to transcriptional blockade with actinomycin D, and instead depend on the translation of pre-existing mRNAs and are blocked by cycloheximide. Ribosome profiling identifies ∼92 mRNAs that are recruited into ribosomes following CD8 T cell stimulation. These mRNAs typically have structured GC and pyrimidine-rich 5' untranslated regions and they encode key regulators of T cell activation and proliferation such as Notch1, Ifngr1, Il2rb, and serine metabolism enzymes Psat1 and Shmt2 (serine hydroxymethyltransferase 2), as well as translation factors eEF1a1 (eukaryotic elongation factor α1) and eEF2 (eukaryotic elongation factor 2). The increased production of receptors of IL-2 and IFN-γ precedes the activation of gene expression and augments cellular signals and T cell activation. Taken together, we identify an early RNA translation program that acts in a feed-forward manner to enable the rapid and dramatic process of CD8 memory T cell expansion and activation.

Indexed as

Glycine HydroxymethyltransferaseInterleukin-25' Untranslated RegionsAnimalsCD8-Positive T-LymphocytesCycloheximideDactinomycinHumansImmunologic MemoryLymphocyte ActivationMemory T CellsMicePeptide Elongation Factor 2Peptide Elongation FactorsPyrimidinesRNA, Messenger5' Untranslated RegionsCycloheximideDactinomycinGlycine HydroxymethyltransferaseInterleukin-2Peptide Elongation Factor 2Peptide Elongation FactorsPyrimidinesRNA, MessengerSerine

Identifiers

PMID36002234
PMCPMC9492650
OpenAlexW4293104153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.